Paper Diagnostics

Paper Diagnostics

The Paper Diagnostics market is expected to register a CAGR of approx. 8.2% over the period of 2023-2030. Paper diagnostics typically involve the integration of biomolecular recognition elements, such as antibodies, nucleic acids, or enzymes, onto paper substrates through various techniques, such as printing, spotting, or immobilization. The paper serves as a solid support matrix for conducting biochemical reactions and capturing target analytes present in biological samples, such as blood, urine, saliva, or environmental samples. The prevalence of cardiovascular diseases, such as heart attacks, heart failure, and myocardial infarctions, liver disorder and other chronic diseases are significant drivers of the paper diagnostics market. As these conditions continue to affect a large portion of the population globally, the demand for diagnosing and monitoring these diseases remains high. For instance, in 2024, there are around 620 million people living with heart and circulatory diseases across the world. Globally it is estimated that 1 in 13 people are living with a heart or circulatory disease. Furthermore, advances in technology have led to the development of more sensitive and specific paper diagnostics kits.

• Based on Kit Type, the market is segmented into lateral flow assays, dipsticks, and paper-based microfluidics. The dipsticks category is expected to witness the highest share during the forecast period. Dipsticks are experiencing growth in the paper diagnostic market due to their simplicity, versatility, and suitability for point-of-care testing applications. Dipstick-based assays typically involve immersing a paper strip (the dipstick) into a sample containing the target analyte, where specific biochemical reactions occur and result in a visible color change, indicating the presence or concentration of the analyte. For instance, in 2021, several companies have developed dipstick-based antigen tests for rapid detection of SARS-CoV-2, the virus that causes COVID-19. These tests offer a convenient and cost-effective solution for mass screening and surveillance efforts during the pandemic.
• Based on device type, the paper diagnostics market has been classified as diagnostic devices, monitoring devices. Among them, the diagnostic device segment is experiencing growth in the paper diagnostic market due to several factors driving demand for innovative and reliable diagnostic technologies. Diagnostic devices encompass a wide range of instruments, platforms, and systems used for performing diagnostic tests, analyzing samples, and interpreting results. These devices play a crucial role in healthcare delivery by enabling accurate and timely diagnosis of various medical conditions. Furthermore, growing awareness of preventive healthcare and the importance of early disease detection has led to an increased emphasis on screening programs and regular health checks.
• Based on application, the market is segmented clinical diagnostics, food quality testing, and environmental monitoring. The clinical diagnostics category is expected to witness the highest CAGR during the forecast period. In the paper diagnostic market, clinical diagnostics refer to the application of paper-based diagnostic tests and devices for diagnosing, monitoring, and managing various medical conditions and diseases in clinical settings. Clinical diagnostics encompasses a wide range of applications, including infectious disease testing, chronic disease management, cancer screening, and monitoring of biomarkers or physiological parameters.
• Based on the End-User, the Paper Diagnostics market has been classified into home healthcare, assisted living healthcare facilities, hospital and clinics, others. Among them, the hospital and clinics category is to witness higher adoption of Paper Diagnostics during the forecast period. The hospital and clinics segment in the end-user segment of the paper diagnostic market is experiencing growth due to several factors driving demand for rapid, cost-effective, and accessible diagnostic solutions in healthcare settings. Hospitals and clinics serve as primary points of care for patients seeking diagnosis, treatment, and management of various medical conditions. Furthermore, there is a growing demand for point-of-care testing in hospitals and clinics, driven by the need for rapid diagnosis, treatment monitoring, and patient management. Paper-based diagnostic tests offer advantages such as rapid turnaround time, ease of use, and portability, making them well-suited for POCT applications in healthcare settings.
• For a better understanding of the market adoption of the Paper Diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America Paper Diagnostics market is expected to continue to grow in the coming years, driven by the increasing prevalence of chronic diseases such as cardiovascular disease, liver disorder, diabetes and many more and growing awareness of paper diagnostics among healthcare professionals and the general population, development of advanced techniques and the rise in treatment option. For instance, in 2019, according to CDC, Every year, about 805,000 people in the United States have a heart attack. About 1 in 5 heart attacks are silent, the damage is done, but the person is not aware of it.
• Some of the major players operating in the market include Bio-Rad Laboratories, Inc., BIOMÉRIEUX., Abbott, Siemens Healthcare Private Limited, Micro Essential Laboratory Inc, Abingdon Health, AnteoTech, Bioneer Corporation, EKF Diagnostics Holdings plc, Acon Laboratories, Inc